HIV-1 Transmission Patterns in Antiretroviral Therapy-Naïve, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing

• Lisa L. Ross ,

  * E-mail: Lisa.L.Ross@viivhealthcare.com

  Affiliation ViiV HealthCare, Research Triangle Park, North Carolina, United States of America

  ⨯
• Joseph Horton,

  Affiliation GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Samiul Hasan,

  Affiliation GlaxoSmithKline, Stevenage, United Kingdom

  ⨯
• James R. Brown,

  Affiliation GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Daniel Murphy,

  Affiliation Clinique Medicale L’Actuel, Montreal, QC, Canada

  ⨯
• Edwin DeJesus,

  Affiliation Orlando Immunology Center, Orlando, Florida, United States of America

  ⨯
• Martin Potter,

  Affiliation McGill University Health Centre, Montreal, QC, Canada

  ⨯
• Anthony LaMarca,

  Affiliation Therafirst Medical Center, Ft Lauderdale, Florida, United States of America

  ⨯
• Ivan Melendez-Rivera,

  Affiliation Centro Ararat, Ponce, Puerto Rico

  ⨯
• Douglas Ward,

  Affiliation Dupont Circle Physicians Group, Washington, DC, United States of America

  ⨯
• Jonathon Uy,

  Affiliation Amicus Therapeutics, Cranbury, New Jersey, United States of America

  ⨯
• Mark S. Shaefer

  Affiliation ViiV HealthCare, Research Triangle Park, North Carolina, United States of America

  ⨯